| Primary information |
|---|
| CancerPPD ID | 1841 |
| PMID | None |
| YEAR | 2005 |
| SEQUENCE | GIGAVLKVLTTGLPALISWIKRKRQQ |
| LENGTH | 26 |
| NAME | MELITTIIN |
| C-ter Modification | Amidation |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | None |
| NATURE | Anticancer |
| ACTIVITY | LD50 =9 µg/ml |
| SOURCE | FLAK peptides |
| Cancer Type | Breast Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | US_06875744_B2 |
| Tissue | Breast |
| CELL LINE | MCF-7 |
| TEST TIME | 24-h |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | CCTTHHHHSSSSCTTHHHHHHHHHCC |
| SMILES | [NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|